Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
Clinical trial NCT05550207 · COMPLETED
Trial details
- NCT number
- NCT05550207
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2024-11-27
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.